Reduced expression of DCN in GC tissues reduced availability for interaction with TGFβ and hence, diminished the involvement of DCN in the TGFβ signaling pathway, further endorsing the tumor suppressive role of DCN in GC. The gene discussed is TGFB1; the disease is neoplasm.